To Bring & Deliver
Novel Therapies
For bio pharma manufacturers with an object to bring
noval therapies in the country
CEO Message
Our History
2012
It all started in 2012 as CLARITY acquires legal entity as a Distribution company.
2014
CLARITY expands in medicine distribution and cooperates, with the companies Roche Pakistan, Eli Lilly & Co., Sandoz (Novartis), Atco Laboratories, CCL Pharmaceuticals, AJM Pharma, Amgomed Pharma and 23 different National & International Pharmaceutical companies distributions.
2017
CLARITY moves towards to an in-house development strategy, it obtains products, and establishes new departments for Marketing and Sales.
2019
CLARITY receives the award letters for its products from SKMCH, MSD SINDH, renowned atomic energy institutes KIRAN, CENAR, NORIN, SINOR, INOR etc.
2020
The ongoing quest for quality assurance of services / products leads to the acquisition of the Certificate of Authenticity for specialized products.
Our Values
Caring
We care about our people, we care about our customers and respect the values of the medical and pharmaceutical community. We are a company of professionals addressing our solutions to healthcare experts and wellinformed consumers. We want to return our profits to the society and the world of health, we want to invest in new solutions and develop products of the highest quality and effectiveness.
Growing
We are constantly growing, learning and improving, as we set ambitious goals and plan for the future. We are growing our workforce and knowledge resources, our products portfolio and our business units aspiring to become the market leader in Pakistan and in the region.
Globalizing
We aim at becoming an international firm within a local traditional context. We apply the international standards in quality, marketing ethics, pharma covigilance and customer support and establishing our presence as developers, traders and marketeer of top quality generic brands.
Diversifying
In 2017, CLARITY has successfully diversified its operations, from distribution and medical trading to the promotion of generic and onpatent products. In 2019 we launched more brands than any other company in our competitive field and in the years 2019-2020 our growth rate has placed us among the top performing healthcare firms, as we operate a wide set of business units.
Our Partners





